Low scores reflecting liver change within the normal ALT range have previously been reported in chronic HBV patients, while significant liver fibrosis and inflammation have been reported in 37% of 192 HBeAg-positive chronic HBV-infected patients with PNALT [14, 15]. This evidence concerns the gene GPT and Hepatic fibrosis.